Linlang Guo
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
Papers in
-
- RNA modifications and cancer 18
- Glycosylation and Glycoproteins Research 11
- Circular RNAs in diseases 7
- Oncology 48
- Lung Cancer Research Studies 31
- Co-authors
- Yanqin Sun (14 shared papers)Yifeng Bai (10 shared papers)Ying Guo (7 shared papers)Weiliang Zhu (22 shared papers)Ting Wei (18 shared papers)Weimei Huang (11 shared papers)Jian Zhang (23 shared papers)Shun Fang (12 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (4 papers)European Journal of Cancer (4 papers)Journal of Thoracic Oncology (4 papers)Annals of Translational Medicine (3 papers)Molecular Cancer (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Linlang Guo
116 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 106
- Cancer Research 1.4k
- Molecular Biology 2.1k
- Oncology 722
- Immunology and Allergy 58
- Pathology and Forensic Medicine 151
Countries citing papers authored by Linlang Guo
This map shows the geographic impact of Linlang Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linlang Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linlang Guo more than expected).
Fields of papers citing papers by Linlang Guo
This network shows the impact of papers produced by Linlang Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linlang Guo. The network helps show where Linlang Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Linlang Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 196 | |
| 2 | 2009 | 159 | |
| 3 | 2019 | 127 | |
| 4 | 2009 | 126 | |
| 5 | 2010 | 126 | |
| 6 | 2012 | 120 | |
| 7 | 2014 | 103 | |
| 8 | 2015 | 99 | |
| 9 | 2019 | 96 | |
| 10 | 2018 | 89 | |
| 11 | 2015 | 80 | |
| 12 | 2012 | 79 | |
| 13 | 2020 | 69 | |
| 14 | 2017 | 68 | |
| 15 | 2015 | 68 | |
| 16 | 2017 | 65 | |
| 17 | 2013 | 57 | |
| 18 | 2018 | 52 | |
| 19 | 2018 | 50 | |
| 20 | 2018 | 45 |
About Linlang Guo
Linlang Guo is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 118 papers that have together received 3.2k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (31 papers), Cancer-related molecular mechanisms research (19 papers), RNA modifications and cancer (18 papers), MicroRNA in disease regulation (15 papers), Glycosylation and Glycoproteins Research (11 papers), Cancer Mechanisms and Therapy (8 papers), Circular RNAs in diseases (7 papers) and Neuroendocrine Tumor Research Advances (7 papers). The work is most often cited by research in Cancer Research (1.4k citations), Molecular Biology (2.1k citations), Oncology (722 citations), Immunology and Allergy (58 citations) and Pathology and Forensic Medicine (151 citations). Linlang Guo has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yanqin Sun, Yifeng Bai, Ying Guo, Weiliang Zhu, Ting Wei, Weimei Huang, Jian Zhang, Shun Fang, Yuchun Niu and Jie Huang. Their work appears in journals such as Biochemical and Biophysical Research Communications, European Journal of Cancer, Journal of Thoracic Oncology, Annals of Translational Medicine and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.